What is CAMO-Net?
The Centres for Antimicrobial Optimisation Network (CAMO-Net) is a unique global research partnership. Our aim is to address antimicrobial resistance and support antimicrobial optimisation for use in humans. This research is underpinned by the values of equity, local leadership, co-production of activities, knowledge mobilisation, mutual cross-regional learning, training, capacity and capabilities strengthening, and output sharing.
Our vision is a world where the appropriate, evidence-based use of antimicrobials is commonplace, supported by equitable availability and accessibility.
CAMO-Net is composed of extraordinary and expert colleagues from around the world. It is a unique opportunity to advance multidisciplinary research to improve and sustain access to effective antimicrobial treatments and address AMR
Professor Alison Holmes OBE
United Kingdom
Mission
CAMO-Net’s mission is to complement and enhance the existing ecosystem of global programmes designed to alleviate the global burden and impact of antimicrobial resistance (AMR) and poorly treated infections by creating and nurturing a sustainable and equitable ecosystem for global research to optimise the use of antimicrobials in humans. This will be achieved through producing contextually relevant tools, technologies, guidelines, and practices that can be readily implemented with the support of governments and policymakers.
Together at CAMO-Net, we are generating new knowledge to mitigate the looming threat of AMR in Africa and beyond. We are influencing policy and empowering the rising generation of scientists in the Global South
Dr Andrew Kambugu
Uganda
Objectives
A comprehensive, contextual understanding of situational data in each National Hub on the progress of interventions to tackle AMR in human populations to identify opportunities to address existing gaps/challenges, with respect to:
- Technology and innovation for optimised prescribing
- Context, culture, and behaviour
- Medicines management.
Harnessing the power of data (quantitative and qualitative) through strategic and targeted studies to generate new knowledge related to optimising antimicrobial use in human populations.
Implementation of co-produced, contextually fit, and sustainable solutions to optimise antimicrobial use targeting innovation, systems and behaviours.
Evaluation of interventions and strategies targeting optimised antimicrobial use through an intersectional approach.
We are focusing on strategies to improve the use of antibiotics in the community and using the shared knowledge that CAMO-Net provides to assess the impact these strategies have on antimicrobial resistance on patients, health workers, and the environment
Professor Anna Levin
Brazil
Structure
CAMO-Net represents the future of equitable global collaboration. We are comprised of:
- Five national hubs in Brazil, India, South Africa, Uganda, and the UK
- Three technical support and development centres in Ghana, Malawi, and Thailand
- Three shadow national sites in Bangladesh, Pakistan, and Timor-Leste.
Our national hubs are equal partners responsible for managing our research. Our national hubs are built on existing collaborations and bring world class researchers together to address the global threat of AMR with local expertise. Our five national hubs are supported by three technical support and development centres, which are quality-assured technology and research and development laboratories to support our activities.
Shadow national sites participate in network activities to actively build research collaborations and capacity with the national hubs. Our shadow national sites are currently identifying national research priorities and will then conduct a pilot project.
The goal for a future iteration of CAMO-Net is that shadow national sites would become National Hubs, and new shadow sites would be identified.
Explore CAMO-Net by location
- National Hub
- Technical Support and Development Centre
- Shadow National Site
CAMO-Net provides the unique opportunity to understand the social contexts of AMR, central to enabling antimicrobial optimisation in low and middle income countries
Professor Marc Mendelson
South Africa
CAMO-Net Members
National hubs: Medicina Universidade de São Paulo (Brazil), Postgraduate Institute of Medical Education and Research (India), Amrita Institute of Medical Sciences (India), University of Cape Town (South Africa), Makerere University (Uganda), Imperial College London (UK), and University of Liverpool (UK).
Technical support and development centres: University of Ghana (Ghana), Kamuzu University (Malawi), and MORU Tropical Health Network (Thailand).
Shadow national sites: Child Health Research Foundation (Bangladesh), Dow University of Health Sciences (Pakistan), and Universidade Da Paz (Timor-Leste).
Working together with our colleagues around the world has been invaluable. We are implementing a multimodal approach towards antimicrobial stewardship in India and this is helping us to optimise the use of antimicrobials and improve people’s lives
Professor Nusrat shafiq
India
Our partner institutions
